12 years ago, there was not much in the way of high-value medical research commercialisation. Publicly funded research was sitting idle, and international companies were bypassing New Zealand in favour of other countries. Diana has been pivotal in developing NZ's MedTech ecosystem and initiatives to grow our capacity in MedTech research translation and commercialisation. Listen to Episode 9 of Chat_GCP where Diana and Chat_GCP host Charles Beasley discuss why the CMDT was started, the importance of screening out bad ideas early, how high rates of commercial success is reached, opportunities for the next 12 years....and much much more.